Involvement of spot 35 protein, a cerebellar protein, in modulation of Purkinje cell activity of the rat cerebellum.
Spot 35 protein, applied iontophoretically, produced inhibition of spontaneous Purkinje cell activity in most cells and augmented the NE- or 5-HT-induced inhibition of spontaneous discharges whereas it hardly affected the inhibitory response of Purkinje cells to GABA, taurine, and beta-alanine, and the excitatory response to glutamate. It is suggested that spot 35 protein may be involved in normal physiological operation of the cerebellum through modulation of the NE or 5-HT system.
Maruyama
S
S
Zhang
G
G
Tamura
Y
Y
Yamakuni
T
T
Takahashi
Y
Y
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D064092:Calbindin 1; D064026:Calbindins; D002135:Calcium-Binding Proteins; D002531:Cerebellum; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D004347:Drug Interactions; D007478:Iontophoresis; D008297:Male; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D011689:Purkinje Cells / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D064030:S100 Calcium Binding Protein G; D012701:Serotonin / Q000494:pharmacology
C576500:Calb1 protein, rat; D064092:Calbindin 1; D064026:Calbindins; D002135:Calcium-Binding Proteins; D009419:Nerve Tissue Proteins; D064030:S100 Calcium Binding Protein G; D012701:Serotonin; D000242:Cyclic AMP; D006152:Cyclic GMP; D009638:Norepinephrine